Table 3.
Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | |
---|---|---|---|---|
Mucious PDAC metastases | ||||
KRAS mutation | 80 | 54 | 53 | 81 |
CK20 + | 65 | 72 | 77 | 59 |
CDX2 + | 63 | 94 | 94 | 63 |
Mucinous lung primaries | ||||
KRAS G12C | 39 | 95 | 88 | 62 |
TTF-1 + | 76 | 96 | 94 | 83 |
Napsin A + | 33 | 100 | 100 | 81 |
KRAS mutated lung primaries | ||||
KRAS G12C | 44 | 96 | 96 | 41 |
KRAS mutated PDAC | ||||
KRAS G12R | 15 | 99 | 86 | 74 |
Abbreviations: NPV, negative predictive value; PDAC, pancreatic ductal adenocarcinoma; PPV, positive predictive value.